Accepting Applications through June 30, 2023
The Endocrine Fellows Foundation (EFF) and the American Society for Bone and Mineral Research (ASBMR) are pleased to offer fellows training in osteoporosis and other metabolic bone diseases a unique opportunity to participate in the Seventeenth Fellows Forum on Osteoporosis and Metabolic Bone Diseases, October 11-12, 2023. The EFF-ASBMR Fellows Forum will be hel prior to the ASBMR Annual Meeting, October 13-16, 2023.
Faculty include a distinguished group of leaders: Drs. Teresita Bellido, John P. Bilezikian, Susan Bukata, Neil Binkley, Bart Clarke, Michael McClung, Paul Miller, Clifford Rosen, Ego Seeman, Deborah Sellmeyer, Michael Whyte. The topics to be presented and discussed will be timely and among the most important in our field. We have balanced the program to be equally strong in clinical and basic aspects of metabolic bone diseases.
The program kicks off with a welcome reception on Wednesday. Thursday is a full day comprised of plenary lectures, breakout workshops, and a poster session. We view the poster session as one of the highlights of the day and look forward to hearing about fellows’ exciting research in this setting.
The program kicks off with a welcome reception on Wednesday. Thursday is a full day comprised of plenary lectures, breakout workshops, and a poster session. We view the poster session as one of the highlights of the day and look forward to hearing about fellows’ exciting research in this setting.
Application Eligibility
Directors of Postdoctoral Subspecialty Training Programs for MDs (e.g. endocrinology, rheumatology, geriatrics, gynecology, orthopedics, women’s health), and Pre- or Postdoctoral PhD Fellowship Training Programs throughout the world are invited to select individuals from their programs who meet the criteria listed below and whose education, in their opinion, would be enhanced by participating in this Forum.
Trainees can be in any of the three categories listed below.
- MD in an accredited, relevant specialty training program (1st, 2nd, or 3rd year)
- PhD in a post-doctoral program (for not more than 3 years)
- PhD trainee
To ensure effective discussions among fellows and faculty, the number of attendees is limited to 60 fellows.
Applications are due by Friday, June 30, 2023.
Selection notification will be sent by July 14, 2023.
Fellows accepted to participate in the Fellows Forum will receive two nights hotel and flight travel assistance.
Attending Both the Fellows Forum and the ASBMR Annual Meeting
- To derive the greatest benefit from this formative experience, we expect that fellows will participate in both the Fellows Forum and the ASBMR Annual Meeting. Thus, selection preference for the Forum will be given to fellows who have submitted abstracts to both the ASBMR Annual Meeting and the Fellows Forum. The same abstract can be submitted to both the Fellows Forum and the ASBMR meeting. Use this link to access the ASBMR Abstract Center and to learn more.
- Fellows participating in the EFF-ASBMR Forum and ASBMR Annual Meeting will also receive:
- 1-year free ASBMR membership starting in January 2024
- Heavily discounted registration fee for the ASBMR Annual Meeting
Faculty Perspectives for the Fifteenth Fellows Forum in Osteoporosis and Metabolic Bone Diseases
Ego Seeman, MD, FRACP, Professor, University of Melbourne, Austin Health, West Heidelberg, Victoria, Australia I think this program is more important than ever now. We have moved into troubling times in many ways, one is the attrition of the founding fathers of the golden age of bone biology. What you are doing is important and it’s a privilege to be part of it.Teresita Bellido, PhD, Professor, University of Arkansas Medical Sciences, Little Rock, Arkansas It will be my honor and pleasure to participate this year again in the Forum. It is just a great program.Bart Clarke, MD, Professor of Medicine, Mayo Clinic, Rochester, Minnesota Happy to participate in this excellent program for our fellows to encourage their careers in bone and mineral metabolism.
Educational Support
This educational activity is supported by unrestricted educational grants from: Amgen, Amolyt Pharma, Ascendis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and Radius.